27923741|t|NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide
27923741|a|Lipopolysaccharide (LPS) might affect the central nervous system by causing neuroinflammation, which subsequently leads to brain damage and dysfunction. In this study, we evaluated the role of nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation in long-term behavioral alterations of 8- week -old male C57BL/6 mice injected intraperitoneally with LPS (5mg/kg). At different time points after injection, we assessed locomotor function with a 24-point neurologic deficit scoring system and the rotarod test; assessed recognition memory with the novel object recognition test; and assessed emotional abnormality (anhedonia and behavioral despair) with the tail suspension test, forced swim test, and sucrose preference test. We also assessed protein expression of NLRP3, apoptosis-associated speck-like protein (ASC), and caspase-1 p10 in hippocampus by Western blotting; measured levels of interleukin (IL)-1β, IL-18, tumor necrosis factor α (TNFα), and IL-10 in hippocampus; measured TNFα and IL-1β in serum by ELISA; and evaluated microglial activity in hippocampus by Iba1 immunofluorescence. We found that LPS - injected mice displayed long-term depression -like behaviors and recognition memory deficit; elevated expression of NLRP3, ASC, and caspase-1 p10; increased levels of IL-1β, IL-18, and TNFα; decreased levels of IL-10; and increased microglial activation. These effects were blocked by the NLRP3 inflammasome inhibitor Ac-Tyr-Val-Ala-Asp-chloromethylketone. The results demonstrate proof of concept that NLRP3 inflammasome activation contributes to long-term behavioral alterations in LPS - exposed mice, probably through enhanced inflammation, and that NLRP3 inflammasome inhibition might alleviate peripheral and brain inflammation and thereby ameliorate long-term behavioral alterations in LPS - exposed mice.
27923741	0	29	NLRP3 inflammasome activation	T038	UMLS:C3272080
27923741	81	85	mice	T204	UMLS:C1521751
27923741	86	94	injected	T058	UMLS:C1533685
27923741	100	118	lipopolysaccharide	T103	UMLS:C0023810
27923741	119	137	Lipopolysaccharide	T103	UMLS:C0023810
27923741	139	142	LPS	T103	UMLS:C0023810
27923741	161	183	central nervous system	T022	UMLS:C3714787
27923741	195	212	neuroinflammation	T038	UMLS:C0021368
27923741	242	254	brain damage	T037	UMLS:C0270611
27923741	259	270	dysfunction	T038	UMLS:C0262405
27923741	280	285	study	T062	UMLS:C2603343
27923741	312	395	nod-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation	T038	UMLS:C3272080
27923741	453	465	C57BL/6 mice	T204	UMLS:C1521751
27923741	466	474	injected	T058	UMLS:C1533685
27923741	475	492	intraperitoneally	T082	UMLS:C0442120
27923741	498	501	LPS	T103	UMLS:C0023810
27923741	543	552	injection	T058	UMLS:C1533685
27923741	566	584	locomotor function	T038	UMLS:C0023946
27923741	592	634	24-point neurologic deficit scoring system	T170	UMLS:C0282574
27923741	643	655	rotarod test	T062	UMLS:C1258024
27923741	666	677	recognition	T038	UMLS:C0524637
27923741	678	684	memory	T038	UMLS:C0025260
27923741	707	723	recognition test	T170	UMLS:C0451414
27923741	738	759	emotional abnormality	T038	UMLS:C0013985
27923741	761	770	anhedonia	T038	UMLS:C0178417
27923741	775	793	behavioral despair	T038	UMLS:C0233514
27923741	804	824	tail suspension test	T058	UMLS:C0022885
27923741	826	842	forced swim test	T058	UMLS:C0022885
27923741	848	871	sucrose preference test	T058	UMLS:C0022885
27923741	890	908	protein expression	T038	UMLS:C1171362
27923741	912	917	NLRP3	T103	UMLS:C1528260
27923741	919	958	apoptosis-associated speck-like protein	T103	UMLS:C0963749
27923741	960	963	ASC	T103	UMLS:C0963749
27923741	970	983	caspase-1 p10	T103	UMLS:C0534519
27923741	987	998	hippocampus	T017	UMLS:C0019564
27923741	1002	1018	Western blotting	T058	UMLS:C0005863
27923741	1039	1058	interleukin (IL)-1β	T103	UMLS:C0021753
27923741	1060	1065	IL-18	T103	UMLS:C0383327
27923741	1067	1090	tumor necrosis factor α	T103	UMLS:C1456820
27923741	1092	1096	TNFα	T103	UMLS:C1456820
27923741	1103	1108	IL-10	T103	UMLS:C0085295
27923741	1112	1123	hippocampus	T017	UMLS:C0019564
27923741	1134	1138	TNFα	T103	UMLS:C1456820
27923741	1143	1148	IL-1β	T103	UMLS:C0021753
27923741	1152	1157	serum	T031	UMLS:C0229671
27923741	1161	1166	ELISA	T058	UMLS:C0014441
27923741	1182	1192	microglial	T017	UMLS:C0206116
27923741	1193	1201	activity	T038	UMLS:C0007613
27923741	1205	1216	hippocampus	T017	UMLS:C0019564
27923741	1220	1243	Iba1 immunofluorescence	T058	UMLS:C0079603
27923741	1259	1262	LPS	T103	UMLS:C0023810
27923741	1265	1273	injected	T058	UMLS:C1533685
27923741	1274	1278	mice	T204	UMLS:C1521751
27923741	1299	1309	depression	T038	UMLS:C0011570
27923741	1330	1341	recognition	T038	UMLS:C0524637
27923741	1342	1356	memory deficit	T038	UMLS:C0233794
27923741	1367	1377	expression	T038	UMLS:C1171362
27923741	1381	1386	NLRP3	T103	UMLS:C1528260
27923741	1388	1391	ASC	T103	UMLS:C0963749
27923741	1397	1410	caspase-1 p10	T103	UMLS:C0534519
27923741	1432	1437	IL-1β	T103	UMLS:C0021753
27923741	1439	1444	IL-18	T103	UMLS:C0383327
27923741	1450	1454	TNFα	T103	UMLS:C1456820
27923741	1476	1481	IL-10	T103	UMLS:C0085295
27923741	1497	1518	microglial activation	T038	UMLS:C1326169
27923741	1554	1582	NLRP3 inflammasome inhibitor	T103	UMLS:C1254351
27923741	1583	1620	Ac-Tyr-Val-Ala-Asp-chloromethylketone	T103	UMLS:C0388131
27923741	1668	1697	NLRP3 inflammasome activation	T038	UMLS:C3272080
27923741	1749	1752	LPS	T103	UMLS:C0023810
27923741	1763	1767	mice	T204	UMLS:C1521751
27923741	1795	1807	inflammation	T038	UMLS:C0021368
27923741	1818	1836	NLRP3 inflammasome	T017	UMLS:C3156614
27923741	1837	1847	inhibition	T038	UMLS:C0021469
27923741	1864	1874	peripheral	T082	UMLS:C0205100
27923741	1879	1884	brain	T017	UMLS:C0006104
27923741	1885	1897	inflammation	T038	UMLS:C0021368
27923741	1957	1960	LPS	T103	UMLS:C0023810
27923741	1971	1975	mice	T204	UMLS:C1521751